Scientists probe immune System's role in ovarian cancer treatment
NCT ID NCT03922776
Summary
This study aimed to learn how the body's immune cells behave in women with advanced ovarian or fallopian tube cancer. Researchers collected blood and tissue samples from 36 participants before and after their standard chemotherapy treatment. The goal was to describe the immune system's profile and see if it could predict how well patients respond to therapy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVARIAN CANCER STAGE IV are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Oscar Lambret
Lille, France, 59020, France
Conditions
Explore the condition pages connected to this study.